BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 16536058)

  • 1. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
    Ohta C; Yamane N; Nakasone I; Onaga S; Nakamura K
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005; 16(2):127-33. PubMed ID: 16536058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal susceptibility of Candida isolates at one institution.
    Katsuragi S; Sata M; Kobayashi Y; Miyoshi T; Yamashita Y; Neki R; Horiuchi C; Yamanaka K; Kamiya C; Iwanaga N; Tanaka H; Ikeda T; Yoshimatsu J
    Med Mycol J; 2014; 55(1):E1-7. PubMed ID: 24682093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
    Komatsu M; Aihara M; Shimakawa K; Iwasaki M; Nagasaka Y; Fukuda S; Abe N; Matsuo S
    Jpn J Antibiot; 2003 Dec; 56(6):705-11. PubMed ID: 15007879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
    Samra Z; Yardeni M; Peled N; Bishara J
    Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):592-5. PubMed ID: 16172856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
    Kamikawa Y; Mori Y; Nagayama T; Fujisaki J; Hirabayashi D; Sakamoto R; Hamada T; Sugihara K
    BMC Oral Health; 2014 Feb; 14():14. PubMed ID: 24552136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
    Park BJ; Park JC; Taguchi H; Fukushima K; Hyon SH; Takatori K
    Biochem Biophys Res Commun; 2006 Aug; 347(2):401-5. PubMed ID: 16831406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
    Karlowsky JA; Hoban DJ; Zhanel GG; Goldstein BP
    Int J Antimicrob Agents; 2006 Feb; 27(2):174-7. PubMed ID: 16414247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
    Pfaller MA; Arikan S; Lozano-Chiu M; Chen Y; Coffman S; Messer SA; Rennie R; Sand C; Heffner T; Rex JH; Wang J; Yamane N
    J Clin Microbiol; 1998 Sep; 36(9):2609-12. PubMed ID: 9705401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.
    Pai MP; Samples ML; Mercier RC; Spilde MN
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2367-76. PubMed ID: 18426896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.
    Guo LN; Xiao M; Cao B; Qu F; Zhan YL; Hu YJ; Wang XR; Liang GW; Gu HT; Qi J; Yuan H; Min R; Wang FY; Liu LJ; Wang HB; Jiang W; Duan XG; Xu WJ; Yu YH; Su JR; Zhang JZ; Nong JQ; Liu SM; Li J; Liu JT; Yue ZG; Yang D; Guo J; Zhao R; Zhang YN; Yang XM; Liu XQ; Hsueh PR; Xu YC
    Future Microbiol; 2017 Sep; 12():1075-1086. PubMed ID: 28836465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
    Arikan S; Sancak B; Hascelik G
    Med Mycol; 2005 Mar; 43(2):171-8. PubMed ID: 15832560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Lindberg E; Hammarström H; Ataollahy N; Kondori N
    Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.